Director Dealing

RNS Number : 6844W

Port Erin Biopharma Investments Ltd

30 January 2013

 



Port Erin Biopharma Investments Limited

 ("Port Erin" or the "Company")

Director's Dealing

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that the Chairman, Jim Mellon, purchased 575,000 Ordinary Shares at an average price of 6.26 pence per share on 29^th January 2013.

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 4,175,000 representing 12.7% of the issued ordinary share capital of the Company.

Enquiries:

Port Erin Biopharma Investments Limited
Denham Eke	([phone]
Libertas Capital Corporate Finance Limited
Sandy Jamieson	([phone]
Rivington Street Corporate Finance Limited
John Levinson	([phone]

 

END

 

 

RDSKBLBXXFFEBBZ